Emily B. Heikamp, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2018 | 1519 | 0.950 |
Why?
|
Bacterial Infections | 2 | 2022 | 1400 | 0.820 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2022 | 158 | 0.750 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2022 | 3596 | 0.680 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2022 | 302 | 0.660 |
Why?
|
TOR Serine-Threonine Kinases | 6 | 2022 | 2064 | 0.660 |
Why?
|
Hyper-IgM Immunodeficiency Syndrome, Type 1 | 1 | 2018 | 3 | 0.630 |
Why?
|
Agranulocytosis | 1 | 2018 | 99 | 0.620 |
Why?
|
History, 20th Century | 7 | 2020 | 2761 | 0.590 |
Why?
|
Emaciation | 1 | 2017 | 5 | 0.590 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2022 | 680 | 0.590 |
Why?
|
Graft vs Host Reaction | 1 | 2017 | 103 | 0.580 |
Why?
|
Wiskott-Aldrich Syndrome | 1 | 2017 | 130 | 0.550 |
Why?
|
Agammaglobulinemia | 1 | 2017 | 172 | 0.510 |
Why?
|
Fever | 2 | 2022 | 1613 | 0.510 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2017 | 159 | 0.500 |
Why?
|
Pediatrics | 4 | 2020 | 3572 | 0.500 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2017 | 224 | 0.480 |
Why?
|
Hyperuricemia | 1 | 2017 | 216 | 0.480 |
Why?
|
Poxviridae Infections | 1 | 2014 | 12 | 0.480 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2017 | 239 | 0.470 |
Why?
|
Probiotics | 1 | 2018 | 366 | 0.470 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2018 | 326 | 0.460 |
Why?
|
Vaccinia virus | 1 | 2014 | 331 | 0.410 |
Why?
|
Immediate-Early Proteins | 1 | 2014 | 449 | 0.380 |
Why?
|
Melanoma, Experimental | 1 | 2014 | 558 | 0.370 |
Why?
|
Multiprotein Complexes | 3 | 2022 | 1115 | 0.340 |
Why?
|
Th1 Cells | 2 | 2014 | 999 | 0.340 |
Why?
|
Th2 Cells | 2 | 2014 | 1012 | 0.340 |
Why?
|
Proto-Oncogene Proteins | 1 | 2022 | 4483 | 0.340 |
Why?
|
Bone Marrow Transplantation | 1 | 2017 | 2681 | 0.330 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 1604 | 0.310 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4718 | 0.290 |
Why?
|
Bone Neoplasms | 1 | 2018 | 2513 | 0.260 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3600 | 0.260 |
Why?
|
Cell Differentiation | 8 | 2022 | 11424 | 0.240 |
Why?
|
Lymphocyte Activation | 3 | 2013 | 5418 | 0.220 |
Why?
|
Glioma | 1 | 2017 | 3394 | 0.200 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 11603 | 0.170 |
Why?
|
Brain Neoplasms | 2 | 2017 | 8895 | 0.160 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2022 | 649 | 0.150 |
Why?
|
Tumor Lysis Syndrome | 1 | 2017 | 40 | 0.150 |
Why?
|
Child | 7 | 2020 | 78996 | 0.150 |
Why?
|
Diencephalon | 1 | 2017 | 54 | 0.150 |
Why?
|
Infant | 4 | 2022 | 35673 | 0.140 |
Why?
|
Lactobacillus | 1 | 2018 | 201 | 0.140 |
Why?
|
Gene Rearrangement | 1 | 2022 | 1112 | 0.140 |
Why?
|
Allopurinol | 1 | 2017 | 196 | 0.140 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2018 | 403 | 0.130 |
Why?
|
Asthma | 1 | 2014 | 6144 | 0.120 |
Why?
|
Hypertrophy | 1 | 2017 | 554 | 0.120 |
Why?
|
Receptors, Notch | 2 | 2010 | 738 | 0.120 |
Why?
|
Remission Induction | 1 | 2020 | 2372 | 0.120 |
Why?
|
Infant, Newborn | 3 | 2019 | 25910 | 0.110 |
Why?
|
Mice, Inbred C57BL | 6 | 2022 | 21724 | 0.110 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2022 | 1572 | 0.110 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2014 | 65 | 0.110 |
Why?
|
Siblings | 1 | 2018 | 824 | 0.110 |
Why?
|
Neoplasm, Residual | 1 | 2018 | 994 | 0.110 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2014 | 168 | 0.110 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2014 | 147 | 0.110 |
Why?
|
Foot | 1 | 2017 | 566 | 0.110 |
Why?
|
Neonatal Screening | 1 | 2017 | 591 | 0.100 |
Why?
|
Hematopoietic Stem Cells | 2 | 2020 | 3360 | 0.100 |
Why?
|
Publishing | 1 | 2020 | 834 | 0.100 |
Why?
|
Humans | 19 | 2022 | 752810 | 0.100 |
Why?
|
DNA, Neoplasm | 1 | 2017 | 1741 | 0.100 |
Why?
|
Neoplasms, Experimental | 2 | 2007 | 1228 | 0.100 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2010 | 1648 | 0.100 |
Why?
|
Uric Acid | 1 | 2017 | 778 | 0.100 |
Why?
|
Hand | 1 | 2017 | 884 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4502 | 0.090 |
Why?
|
Mice | 10 | 2022 | 80551 | 0.090 |
Why?
|
Syndrome | 1 | 2017 | 3273 | 0.090 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4112 | 0.090 |
Why?
|
Adaptive Immunity | 1 | 2014 | 721 | 0.080 |
Why?
|
Periodicals as Topic | 1 | 2020 | 1446 | 0.080 |
Why?
|
Infant, Premature | 1 | 2018 | 2061 | 0.080 |
Why?
|
Chromatin | 1 | 2020 | 2916 | 0.080 |
Why?
|
Tumor Burden | 1 | 2014 | 1875 | 0.080 |
Why?
|
Cell Line, Tumor | 3 | 2022 | 16739 | 0.080 |
Why?
|
Gene Expression Regulation | 3 | 2020 | 11882 | 0.080 |
Why?
|
Risk Assessment | 2 | 2019 | 23785 | 0.070 |
Why?
|
T-Lymphocytes | 3 | 2013 | 10049 | 0.070 |
Why?
|
Umbilical Veins | 1 | 2007 | 425 | 0.070 |
Why?
|
Acute Disease | 1 | 2017 | 7217 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2783 | 0.070 |
Why?
|
Immunoglobulin Variable Region | 1 | 2007 | 418 | 0.070 |
Why?
|
Animals | 11 | 2022 | 166825 | 0.070 |
Why?
|
Prospective Studies | 2 | 2022 | 53833 | 0.070 |
Why?
|
DNA Methylation | 1 | 2020 | 4298 | 0.070 |
Why?
|
Endothelial Cells | 2 | 2010 | 3513 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 17650 | 0.070 |
Why?
|
Exosomes | 1 | 2010 | 422 | 0.060 |
Why?
|
Immunity | 1 | 2011 | 994 | 0.060 |
Why?
|
Interferon-gamma | 1 | 2014 | 3128 | 0.060 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2011 | 973 | 0.060 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 1873 | 0.060 |
Why?
|
Signal Transduction | 6 | 2013 | 23235 | 0.060 |
Why?
|
Mice, Knockout | 3 | 2014 | 14296 | 0.050 |
Why?
|
Genetic Variation | 1 | 2018 | 6510 | 0.050 |
Why?
|
Recombination, Genetic | 1 | 2007 | 1527 | 0.050 |
Why?
|
Immunotherapy | 1 | 2018 | 4601 | 0.050 |
Why?
|
Cells, Cultured | 3 | 2014 | 18918 | 0.050 |
Why?
|
Immunologic Memory | 2 | 2022 | 1326 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12918 | 0.050 |
Why?
|
Trans-Activators | 1 | 2011 | 2851 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2013 | 4286 | 0.050 |
Why?
|
Transcription Factors | 3 | 2020 | 12060 | 0.050 |
Why?
|
Neovascularization, Pathologic | 2 | 2007 | 2624 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 13905 | 0.040 |
Why?
|
SOXB1 Transcription Factors | 1 | 2020 | 287 | 0.040 |
Why?
|
B-Lymphocytes | 2 | 2011 | 4705 | 0.040 |
Why?
|
Time Factors | 1 | 2020 | 39885 | 0.040 |
Why?
|
Proteins | 1 | 2011 | 6015 | 0.030 |
Why?
|
Homeodomain Proteins | 2 | 2020 | 2408 | 0.030 |
Why?
|
Lysine | 1 | 2020 | 990 | 0.030 |
Why?
|
Sirolimus | 1 | 2022 | 1535 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2007 | 4419 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13558 | 0.030 |
Why?
|
Calcium-Binding Proteins | 2 | 2010 | 1062 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2020 | 2496 | 0.030 |
Why?
|
Mice, SCID | 2 | 2010 | 2617 | 0.030 |
Why?
|
Mutation | 1 | 2017 | 29712 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2018 | 64288 | 0.020 |
Why?
|
Transplantation, Heterologous | 2 | 2010 | 2368 | 0.020 |
Why?
|
Mice, Inbred BALB C | 2 | 2010 | 6112 | 0.020 |
Why?
|
Histones | 1 | 2020 | 2566 | 0.020 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2011 | 200 | 0.020 |
Why?
|
United States | 1 | 2017 | 71434 | 0.020 |
Why?
|
Adolescent | 1 | 2017 | 86822 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2010 | 2900 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2011 | 946 | 0.020 |
Why?
|
Immunoblotting | 1 | 2011 | 1649 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3705 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2011 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2013 | 1591 | 0.020 |
Why?
|
Cricetulus | 1 | 2007 | 816 | 0.020 |
Why?
|
Frameshift Mutation | 1 | 2007 | 388 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2011 | 3598 | 0.020 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 811 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5786 | 0.020 |
Why?
|
Neuropeptides | 1 | 2011 | 942 | 0.020 |
Why?
|
CHO Cells | 1 | 2007 | 1390 | 0.020 |
Why?
|
Cell Lineage | 1 | 2013 | 2511 | 0.010 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2007 | 498 | 0.010 |
Why?
|
Up-Regulation | 1 | 2013 | 4115 | 0.010 |
Why?
|
Th17 Cells | 1 | 2011 | 775 | 0.010 |
Why?
|
Cricetinae | 1 | 2007 | 2423 | 0.010 |
Why?
|
Female | 4 | 2018 | 386339 | 0.010 |
Why?
|
Male | 3 | 2018 | 355160 | 0.010 |
Why?
|
Neovascularization, Physiologic | 1 | 2010 | 1336 | 0.010 |
Why?
|
Cell Communication | 1 | 2010 | 1633 | 0.010 |
Why?
|
Probability | 1 | 2007 | 2477 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2007 | 2049 | 0.010 |
Why?
|
Stromal Cells | 1 | 2007 | 1317 | 0.010 |
Why?
|
Amino Acids | 1 | 2007 | 1714 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2011 | 5840 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2011 | 4071 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2011 | 3031 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2011 | 4932 | 0.010 |
Why?
|
Models, Genetic | 1 | 2007 | 3444 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2007 | 3467 | 0.010 |
Why?
|
Base Sequence | 1 | 2007 | 12432 | 0.010 |
Why?
|
Cytokines | 1 | 2011 | 7239 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2011 | 5598 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2007 | 17608 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2007 | 9460 | 0.010 |
Why?
|
Software | 1 | 2007 | 4422 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2007 | 10358 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2007 | 9107 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 9554 | 0.010 |
Why?
|